MXCT — MaxCyte Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for MaxCyte, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	16.7	34.8	255	227	168
Net Total Accounts Receivable
Net Total Receivables	3.24	5.17	6.88	13.6	5.78
Total Inventory
Total Other Current Assets
Total Current Assets	24.5	45.3	270	252	190
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5.53	6.49	13.4	33.6	34.8
Long Term Investments
Other Long Term Assets
Total Assets	30	51.8	284	287	268
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	9.34	11.6	15.6	15.4	17.9
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	16.4	18.6	21.2	32.7	36.1
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	13.6	33.2	263	254	232
Total Liabilities & Shareholders' Equity	30	51.8	284	287	268
Total Common Shares Outstanding